文献速递皮肤肿瘤

皮肤黑色素瘤中LAG-3与TIGIT的表达及其与PD-1的相关性

Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes.
PubMed 文献 · J Am Acad Dermatol · 2019-03-14

该研究对124例黑色素瘤患者的诊断组织行免疫组化,检测LAG-3、TIGIT与PD-1表达并分析其与临床病理特征及生存的关系。结果显示肿瘤浸润淋巴细胞上LAG-3、TIGIT表达与PD-1显著相关,且与较深Breslow厚度、淋巴结受累和晚期疾病相关,高表达者生存更差,而PD-1高表达不预测生存。

要点

  • LAG-3与TIGIT高表达是皮肤黑色素瘤独立的不良预后因素。
  • LAG-3、TIGIT表达与PD-1表达及深Breslow厚度、淋巴结受累、晚期相关。
  • PD-1高表达与预后相关临床病理变量及生存均无显著关联。

核心结论

  • LAG-3与TIGIT表达是皮肤黑色素瘤的独立不良预后因素。

研究设计与样本

  • 回顾性单中心研究,对124例黑色素瘤患者的诊断组织行免疫组化检测LAG-3、TIGIT与PD-1表达。
  • 按LAG-3、TIGIT、PD-1表达分析临床病理特征与生存。

主要发现

  • 肿瘤浸润淋巴细胞上LAG-3与TIGIT表达与PD-1表达显著相关。
  • LAG-3与TIGIT表达与较深Breslow厚度、淋巴结受累及晚期疾病显著相关。
  • LAG-3或TIGIT高表达均与更差生存相关。
  • 按Breslow厚度分层分析显示LAG-3与TIGIT无论肿瘤厚度均有预后意义。
  • PD-1表达与预后相关临床病理变量无关,PD-1高表达不预测生存。

临床怎么用

  • 可考虑将肿瘤浸润淋巴细胞LAG-3、TIGIT表达作为皮肤黑色素瘤预后评估的参考指标。
  • PD-1表达不宜单独用于该人群的预后判断。

局限性

  • 回顾性单中心研究。
  • 存在1型错误(假阳性)的可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphocyte-activating gene 3 (LAG-3) and T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibition motif (TIGIT) domains are emerging checkpoint proteins. OBJECTIVE: We evaluated LAG-3 and TIGIT protein expression patterns, correlated these patterns with programmed cell death 1 (PD-1) protein expression, and determined their effects on clinicopathologic characteristics and biologic responses in melanoma. METHODS: Diagnostic tissue from 124 patients with melanoma were evaluated for LAG-3, TIGIT, and PD-1 expression by immunohistochemistry. Clinicopathologic features and survival were analyzed according to the expression of LAG-3, TIGIT, and PD-1. RESULTS: LAG-3 and TIGIT expression on tumor-infiltrating lymphocytes were significantly correlated with that of PD-1 and was also significantly associated with negative prognostic factors: deeper Breslow thickness, lymph node involvement, and advanced stage of disease. However, PD-1 expression was not associated with clinicopathologic variables of prognostic significance. High expression of either LAG-3 or TIGIT was associated with worse survival. Subgroup analysis on the basis of Breslow thickness showed that both LAG-3 and TIGIT have prognostic significance regardless of tumor thickness. High expression of PD-1 was not predictive of survival. LIMITATIONS: Retrospective study in a single institution and possibility of type 1 error. CONCLUSION: Expression of LAG-3 and TIGIT represents an independent unfavorable prognostic factor in cutaneous melanoma.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Lee WJ, Lee YJ, Choi ME, et al. Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes. J Am Acad Dermatol. 2019. PMID: 30880064. doi:10.1016/j.jaad.2019.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。